Re: Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-Risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-Third Dose versus Full Dose and 1 Year versus 3 Years of Maintenance

Re: Final Results of an EORTC-GU Cancers

Re: Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of Maintenance

✍ Inman, Brant A. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Re: Final Results of an EORTC-GU Cancers

Re: Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of Maintenance

✍ Solsona, Eduardo 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 55 KB

1050 Bacillus Calmette-Guerin: One third

1050 Bacillus Calmette-Guerin: One third dose versus full dose and one year versus three years of maintenance. Final results of an EORTC GU Cancers Group randomized trial in non muscle invasive bladder cancer

✍ Brausi, M.A.; Oddens, J.R.; Sylvester, R.J.; Bono, A.V.; Van De Beek, C.; Van An 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 17 KB

1665 BACILLUS CALMETTE-GUERIN ONE THIRD

1665 BACILLUS CALMETTE-GUERIN ONE THIRD DOSE VERSUS FULL DOSE AND ONE YEAR VERSUS THREE YEARS OF MAINTENANCE. FINAL RESULTS OF EORTC GU CANCERS GROUP RANDOMIZED TRIAL 30962 IN NON MUSCLE INVASIVE BLADDER CANCER

✍ Brausi, Maurizio; Oddens, Jorg; Sylvester, Richard; Bono, Aldo; van de Beek, Cee 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 49 KB

PROGNOSTIC FACTORS IN PATIENTS WITH INTE

PROGNOSTIC FACTORS IN PATIENTS WITH INTERMEDIATE AND HIGH RISK STAGE TA T1 PAPILLARY CARCINOMA OF THE BLADDER TREATED WITH MAINTENANCE EPIRUBICIN OR MAINTENANCE BACILLUS CALMETTE-GUERIN. RESULTS OF EORTC GU GROUP STUDY 30911

✍ R.J. Sylvester; W. Oosterlinck; M.A. Brausi; W.J. Kirkels; F. Calais Da Silva; T 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 70 KB

PROGNOSTIC FACTORS IN PATIENTS WITH INTE

PROGNOSTIC FACTORS IN PATIENTS WITH INTERMEDIATE AND HIGH RISK STAGE Ta T1 PAPILLARY CARCINOMA OF THE BLADDER TREATED WITH MAINTENANCE EPIRUBICIN OR MAINTENANCE BACILLUS CALMETTE-GUERIN. RESULTS OF EORTC GU GROUP STUDY 30911

✍ Sylvester, Richard; Oosterlinck, Willem; Brausi, Maurizio; Kirkels, Wim J; Da Si 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 146 KB